A5029486208- melanin and skin pigmentation
- Atherosclerosis and Cardiovascular Diseases
- Mast cells and histamine
- Biochemical Analysis and Sensing Techniques
- Skin Protection and Aging
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Autoimmune Bullous Skin Diseases
- Olfactory and Sensory Function Studies
- Cell Adhesion Molecules Research
- Acne and Rosacea Treatments and Effects
- Herpesvirus Infections and Treatments
- Genetic and rare skin diseases.
- Dermatologic Treatments and Research
- Antioxidant Activity and Oxidative Stress
- RNA regulation and disease
- Dermatological and COVID-19 studies
- Dermatological diseases and infestations
- Ocular Surface and Contact Lens
- Reproductive System and Pregnancy
- Vestibular and auditory disorders
- Hair Growth and Disorders
- Long-Term Effects of COVID-19
- Oral Health Pathology and Treatment
- Urticaria and Related Conditions
Pontifícia Universidade Católica do Paraná
2016-2025
Universidade do Estado do Amazonas
2023
Fundação de Apoio a Pesquisa do Estado de Goiás
2023
Santa Casa de Misericórdia de Passos
2022
Santa Casa de Misericórdia de Marília
2011-2020
Irmandade da Santa Casa de Misericórdia de São Paulo
2012
Pigment Cell & Melanoma ResearchVolume 28, Issue 3 p. 363-369 Meeting Report Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus Viktoria Eleftheriadou, Corresponding Author Eleftheriadou Centre of Evidence Based Dermatology, University Nottingham, UKCORRESPONDENCE Khaled Ezzedine and e-mails: khaled.ezzedine@chu-bordeaux.fr; viktoria.eleftheriadou@nottingham.ac.ukSearch more papers by this authorKim Thomas, Kim Thomas UKSearch authorNanja van Geel,...
A plethora of prolonged COVID-19 symptoms, or late manifestations has been reported after acute disease and labeled "post-COVID". The aim this study was to identify the prevalence risk factors for post-COVID up 12 weeks onset COVID-19. An electronic survey conducted evaluate post-COVID-19 severity, demographics, pre-existing diseases. participants were recruited through 88,648 SMS messages, post on social media. associations between variables explored multivariate models. From 6,958...
What is known about this subject in regard to women and their families? Endometriosis a chronic estrogen-dependent disorder with unclear pathogenesis, although the immune system inflammatory response are directly involved its development. Despite increasing population prevalence of endometriosis modern times potential shared pathophysiological mechanisms some dermatoses associated immunological, inflammatory, hormonal factors, date, no study has investigated co-occurrence dermatoses. new...
Atopic dermatitis (AD) burden increases with disease severity. Characterize the real-world of AD in Brazil, Mexico, and Argentina. MEASURE-AD enrolled patients (≥12-years old) moderate to severe receiving or candidates for systemic therapy between December 2019-December 2020. Patient characteristics, treatments, outcomes were recorded during one office visit. Primary outcome measures included worst itch/past 24hours (Worst Pruritus Numerical Rating Scale [WP-NRS]), quality life (QoL,...
We report the case of a 25-year-old patient who became pregnant during ustekinumab therapy. Treatment was suspended immediately after pregnancy had been confirmed. The an uneventful and her child is currently 14 months old, with adequate development to age. Four reports treatment have reported one resulted in miscarriage.
The Vitiligo Global Issues Consensus Conference (VGICC), through an international e-Delphi consensus, concluded that 'repigmentation' and 'maintenance of gained repigmentation' are essential core outcome measures in future vitiligo trials. This VGICC position paper addresses these topics two sections includes atlas depicting repigmentation patterns color match. first section delineates mechanisms characteristics repigmentation, the second summarizes outcomes meeting discussions e-surveys on...
Interest has increased in comorbidities associated with psoriasis and their effects on health-related quality of life (HRQoL). This study aimed to evaluate the prevalence metabolic syndrome (MetS) psoriatic arthritis (PsA) investigate HRQoL hypertension, type 2 diabetes mellitus (T2DM), obesity dyslipidemia. In a cross-sectional design, patients diagnosed plaque answered an interview standardized questionnaires (Dermatology Life Quality Index questionnaire [DLQI], 36-Item Short Form Health...
Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease, which manifests through hypochromic achromic macules, with loss in quality of life. The prevalence vitiligo Brazil was determined to be 0.54%. There no on-label medication for its treatment. To date, Brazilian consensus on the treatment had been written. objective this group dermatologists experience disease reach clinical and surgical vitiligo, based articles best scientific evidence. Seven were invited, each...
Vitiligo is a disease that causes macules and achromic and/or hypochromic patches, which can affect from small areas to the entire tegument. Treatment options are few generally ineffective. Recently, some case reports have appeared show positive results with use of Janus kinase inhibitors associated phototherapy. This report details patient rheumatoid arthritis vitiligo in treatment for two years, whose condition partially improved initially after eight months oral tofacitinib at dose 5 mg...
Data on chronic plaque psoriasis severity and its potential clinical lifestyle implications in the Brazilian population are limited. The primary aim of this study was to assess Brazil. Further objectives included evaluating associations between disease demographic, lifestyle, characteristics, health-related quality life (HRQOL), work productivity.This observational (non-interventional) cross-sectional conducted 26 dermatologic clinics across 11 states. Psoriasis assessed using investigator...